Company Registration No. 10500377 (England and Wales)
Busa Lifesciences Ltd
Unaudited accounts
for the year ended 30 November 2021
Busa Lifesciences Ltd
Unaudited accounts
Contents
Busa Lifesciences Ltd
Company Information
for the year ended 30 November 2021
Company Number
10500377 (England and Wales)
Registered Office
BUSA HOUSE 132-134
GREAT ANCOATS STREET
MANCHESTER
M4 6DE
ENGLAND
Accountants
Enso Accountants Ltd
Busa Lifesciences Ltd
Statement of financial position
as at 30 November 2021
Tangible assets
28,209
2,968
Cash at bank and in hand
100,894
119,553
Creditors: amounts falling due within one year
(47,980)
(61,200)
Net current assets
62,081
112,333
Called up share capital
150,000
150,000
Profit and loss account
(59,710)
(34,699)
Shareholders' funds
90,290
115,301
For the year ending 30 November 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 1 August 2022 and were signed on its behalf by
Husein Salem
Director
Company Registration No. 10500377
Busa Lifesciences Ltd
Notes to the Accounts
for the year ended 30 November 2021
Busa Lifesciences Ltd is a private company, limited by shares, registered in England and Wales, registration number 10500377. The registered office is BUSA HOUSE 132-134, GREAT ANCOATS STREET, MANCHESTER, M4 6DE, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
5 Year Straight Line
4
Tangible fixed assets
Plant & machinery
Motor vehicles
Total
Cost or valuation
At cost
At cost
At 1 December 2020
3,180
-
3,180
At 30 November 2021
3,180
31,206
34,386
At 1 December 2020
212
-
212
Charge for the year
636
5,329
5,965
At 30 November 2021
848
5,329
6,177
At 30 November 2021
2,332
25,877
28,209
At 30 November 2020
2,968
-
2,968
5
Debtors: amounts falling due within one year
2021
2020
Debtors: amounts falling due after more than one year
Other debtors
9,167
53,980
Busa Lifesciences Ltd
Notes to the Accounts
for the year ended 30 November 2021
6
Creditors: amounts falling due within one year
2021
2020
Bank loans and overdrafts
47,980
50,000
7
Average number of employees
During the year the average number of employees was 2 (2020: 2).
